Matches in Wikidata for { <http://www.wikidata.org/entity/Q92822710> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q92822710 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92822710 description "scientific article published on 21 January 2020" @default.
- Q92822710 description "wetenschappelijk artikel" @default.
- Q92822710 description "наукова стаття, опублікована 21 січня 2020" @default.
- Q92822710 name "Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study" @default.
- Q92822710 name "Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study" @default.
- Q92822710 type Item @default.
- Q92822710 label "Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study" @default.
- Q92822710 label "Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study" @default.
- Q92822710 prefLabel "Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study" @default.
- Q92822710 prefLabel "Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study" @default.
- Q92822710 P1433 Q92822710-98E8608F-99BE-4F8B-926E-09CFF607C16A @default.
- Q92822710 P1476 Q92822710-E1442D58-C9F5-4463-BAF1-B9D10249A724 @default.
- Q92822710 P2093 Q92822710-005142D1-4EE6-46AA-B601-86056D021714 @default.
- Q92822710 P2093 Q92822710-00774C23-C3AD-4CBD-8FFB-DF56FA30DBCC @default.
- Q92822710 P2093 Q92822710-2518A1A6-E7E6-4B07-BB9C-1D6C25E0F6A4 @default.
- Q92822710 P2093 Q92822710-29C2BCC8-F074-4412-8D47-1A9AEAF6FBB2 @default.
- Q92822710 P2093 Q92822710-3BF78791-EFB1-451B-A08A-2CEA24D30C31 @default.
- Q92822710 P2093 Q92822710-8B3421BA-58EF-43FC-9FF6-CC6CB6BFA29C @default.
- Q92822710 P2093 Q92822710-9ECF877D-C9BF-4FA5-8313-22FA1C258923 @default.
- Q92822710 P2093 Q92822710-BD59C6D1-D53F-4458-B0CF-825F98552DB3 @default.
- Q92822710 P2093 Q92822710-BE995F00-260B-4D65-8866-9CB2FD504C78 @default.
- Q92822710 P2093 Q92822710-C5C6ABB5-C6C7-4C5E-9E01-853CED7DD4F4 @default.
- Q92822710 P2093 Q92822710-CA9A53E0-54BF-4ADB-8974-11CA5B04305B @default.
- Q92822710 P2093 Q92822710-E19BA54B-7862-4AA8-AD4F-39444210D3FD @default.
- Q92822710 P2093 Q92822710-EDC70C61-B296-45BC-BA98-371299793EAE @default.
- Q92822710 P31 Q92822710-93DF7376-1FA2-4383-BDF7-C3A58686205B @default.
- Q92822710 P356 Q92822710-542B279A-F6F7-4ABB-A9B5-B59BB7A46ECD @default.
- Q92822710 P50 Q92822710-97DADC3E-F674-45D7-8331-C124C18747F0 @default.
- Q92822710 P50 Q92822710-AE223D3C-3F30-4439-AC64-C28EC45F561F @default.
- Q92822710 P50 Q92822710-DA2E1F79-4F81-4DFD-A3C7-B8F8DFAC4DB7 @default.
- Q92822710 P577 Q92822710-A028C244-68D3-4ECA-AAA2-68671787AC0F @default.
- Q92822710 P698 Q92822710-9A394626-3853-4F39-9B16-370963E951B6 @default.
- Q92822710 P921 Q92822710-A6851749-AE52-45AC-817F-4F2AD2A84CC1 @default.
- Q92822710 P356 1078-0432.CCR-19-3061 @default.
- Q92822710 P698 31964785 @default.
- Q92822710 P1433 Q332253 @default.
- Q92822710 P1476 "Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study" @default.
- Q92822710 P2093 "Bryone J Kuss" @default.
- Q92822710 P2093 "Carol Moreno" @default.
- Q92822710 P2093 "Constantine S Tam" @default.
- Q92822710 P2093 "David T Weaver" @default.
- Q92822710 P2093 "Hagop Youssoufian" @default.
- Q92822710 P2093 "James Essell" @default.
- Q92822710 P2093 "Julio Delgado" @default.
- Q92822710 P2093 "Marco Montillo" @default.
- Q92822710 P2093 "Matthew S Davids" @default.
- Q92822710 P2093 "Nicole Lamanna" @default.
- Q92822710 P2093 "Stephanie Lustgarten" @default.
- Q92822710 P2093 "Ulrich Jäger" @default.
- Q92822710 P2093 "Zsolt Nagy" @default.
- Q92822710 P31 Q13442814 @default.
- Q92822710 P356 "10.1158/1078-0432.CCR-19-3061" @default.
- Q92822710 P50 Q38804038 @default.
- Q92822710 P50 Q47158807 @default.
- Q92822710 P50 Q48086375 @default.
- Q92822710 P577 "2020-01-21T00:00:00Z" @default.
- Q92822710 P698 "31964785" @default.
- Q92822710 P921 Q27077129 @default.